Medtronic PLC (LTS:0Y6X)
$ 81.63 1.13 (1.41%) Market Cap: 104.56 Bil Enterprise Value: 125.12 Bil PE Ratio: 25.24 PB Ratio: 2.18 GF Score: 78/100

Medtronic PLC Conversation and Q&A Session with CST Team Transcript

Dec 17, 2021 / 06:30PM GMT
Release Date Price: $102.82 (+0.78%)
Ryan Weispfenning
Medtronic plc - VP of IR

I think we'll go ahead and get started. Hello, everyone. I'm Ryan Weispfenning, Vice President and Head of Investor Relations at Medtronic. Thank you for joining us today on a Friday for our Medtronic General Manager Call Series. Today marks the third episode in 2021 of the series and the sixth since we initiated these in late 2019. As you know, we have a full pipeline of innovative products and ongoing launches across our businesses. And with these calls, we want to highlight these, the pipeline items, and give you an opportunity to hear from and interact with our presidents and general managers who are leading these businesses.

For today's event, we're pleased to feature our Cranial and Spinal Technologies operating unit, which we call CST. This is in our neuroscience portfolio. I'm going to invite each of our CST leaders to turn on their video one by one in a moment. But for now, I'll introduce them by name and title. So joining me today is Brett Wall, who's the EVP and President of our Neuroscience portfolio. Next is Carlton Weatherby, who's the VP

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot